Amgen kicks off two pivotal Phase 3 trials for MariTide as it aims to capture the booming obesity drug market.
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
Category: Banking & Insurance
Claire’s Sells Most North American Business to Ames Watson After Bankruptcy Filing, Pauses Liquidation to Maximize Value
Claire’s announced Wednesday it is selling most of its North American business in an effort to stave off liquidation after filing for bankruptcy
Eli Lilly’s oral weight-loss pill orforglipron clears key Phase 3 trial, paving the way for global approval
Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.